Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Gold nanoparticle platforms as drug and biomacromolecule delivery systems.

Duncan B, Kim C, Rotello VM.

J Control Release. 2010 Nov 20;148(1):122-7. doi: 10.1016/j.jconrel.2010.06.004. Epub 2010 Jun 11. Review.

2.

Monolayer coated gold nanoparticles for delivery applications.

Rana S, Bajaj A, Mout R, Rotello VM.

Adv Drug Deliv Rev. 2012 Feb;64(2):200-16. doi: 10.1016/j.addr.2011.08.006. Epub 2011 Sep 6. Review.

3.

Gold nanoparticle-based drug delivery platform for antineoplastic chemotherapy.

Liang JJ, Zhou YY, Wu J, Ding Y.

Curr Drug Metab. 2014;15(6):620-31. Review.

PMID:
24909418
4.

Multimodal drug delivery using gold nanoparticles.

Kim CK, Ghosh P, Rotello VM.

Nanoscale. 2009 Oct;1(1):61-7. doi: 10.1039/b9nr00112c. Epub 2009 Sep 4. Review.

PMID:
20644861
5.

Gold nanoparticles in delivery applications.

Ghosh P, Han G, De M, Kim CK, Rotello VM.

Adv Drug Deliv Rev. 2008 Aug 17;60(11):1307-15. doi: 10.1016/j.addr.2008.03.016. Epub 2008 Apr 10. Review.

PMID:
18555555
6.

Gold nanoparticle (AuNP)-based drug delivery and molecular imaging for biomedical applications.

Jeong EH, Jung G, Hong CA, Lee H.

Arch Pharm Res. 2014 Jan;37(1):53-9. doi: 10.1007/s12272-013-0273-5. Epub 2013 Nov 12. Review.

PMID:
24214174
7.

Gold nanoparticles: emerging paradigm for targeted drug delivery system.

Kumar A, Zhang X, Liang XJ.

Biotechnol Adv. 2013 Sep-Oct;31(5):593-606. doi: 10.1016/j.biotechadv.2012.10.002. Epub 2012 Oct 27. Review.

PMID:
23111203
8.

Design and applications of gold nanoparticle conjugates by exploiting biomolecule-gold nanoparticle interactions.

Su S, Zuo X, Pan D, Pei H, Wang L, Fan C, Huang W.

Nanoscale. 2013 Apr 7;5(7):2589-99. doi: 10.1039/c3nr33870c. Review.

PMID:
23423633
9.

Gold nanoparticle surface functionalization: mixed monolayer versus hetero bifunctional peg linker.

Harrison E, Coulter JA, Dixon D.

Nanomedicine (Lond). 2016 Apr;11(7):851-65. Review.

PMID:
27021417
10.

Multi-functional gold nanoparticles for drug delivery.

Han G, Ghosh P, Rotello VM.

Adv Exp Med Biol. 2007;620:48-56. Review.

PMID:
18217334
11.

Gold nanoparticles in cancer therapy.

Lim ZZ, Li JE, Ng CT, Yung LY, Bay BH.

Acta Pharmacol Sin. 2011 Aug;32(8):983-90. doi: 10.1038/aps.2011.82. Epub 2011 Jul 11. Review.

12.

Current trends in using polymer coated gold nanoparticles for cancer therapy.

Muddineti OS, Ghosh B, Biswas S.

Int J Pharm. 2015 Apr 30;484(1-2):252-67. doi: 10.1016/j.ijpharm.2015.02.038. Epub 2015 Feb 18. Review.

PMID:
25701627
13.

Protein-gold nanoparticle interactions and their possible impact on biomedical applications.

Liu J, Peng Q.

Acta Biomater. 2017 Jun;55:13-27. doi: 10.1016/j.actbio.2017.03.055. Epub 2017 Apr 2. Review.

PMID:
28377307
14.

Recent advances in polymer protected gold nanoparticles: synthesis, properties and applications.

Shan J, Tenhu H.

Chem Commun (Camb). 2007 Nov 28;(44):4580-98. Epub 2007 Jul 9. Review.

PMID:
17989803
15.

Metal based frameworks for drug delivery systems.

Popescu RC, Grumezescu AM.

Curr Top Med Chem. 2015;15(15):1532-42. Review.

PMID:
25877086
16.

Radiosensitization by gold nanoparticles: Will they ever make it to the clinic?

Cui L, Her S, Borst GR, Bristow RG, Jaffray DA, Allen C.

Radiother Oncol. 2017 Sep;124(3):344-356. doi: 10.1016/j.radonc.2017.07.007. Epub 2017 Aug 4. Review.

PMID:
28784439
17.

Multifunctional gold nanoparticles for diagnosis and therapy of disease.

Mieszawska AJ, Mulder WJ, Fayad ZA, Cormode DP.

Mol Pharm. 2013 Mar 4;10(3):831-47. doi: 10.1021/mp3005885. Epub 2013 Feb 11. Review.

18.

Gold nanoparticles for nucleic acid delivery.

Ding Y, Jiang Z, Saha K, Kim CS, Kim ST, Landis RF, Rotello VM.

Mol Ther. 2014 Jun;22(6):1075-1083. doi: 10.1038/mt.2014.30. Epub 2014 Mar 6. Review.

19.

Ultraviolet light-mediated drug delivery: Principles, applications, and challenges.

Barhoumi A, Liu Q, Kohane DS.

J Control Release. 2015 Dec 10;219:31-42. doi: 10.1016/j.jconrel.2015.07.018. Epub 2015 Jul 21. Review.

PMID:
26208426

Supplemental Content

Support Center